Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eriko Takehara"'
Autor:
Yasunori Sasaki, Haruna Azetsu, Wataru Akita, Eriko Takehara, Michio Kuwahara, Keita Kusaka, Satomi Shikuma
Publikováno v:
Therapeutic Apheresis and Dialysis. 20:12-19
Cardiovascular events (CVEs) are major complications in patients with chronic kidney disease (CKD). However, few studies have investigated the effects of CVEs on end-stage renal disease (ESRD) and mortality of pre-dialysis patients. We followed 377 C
Autor:
Takashi Oda, Satomi Shikuma, Wataru Akita, Motoko Chiga, Shintaro Mandai, Takayasu Mori, Eriko Takehara, Shinichi Uchida, Michio Kuwahara
Publikováno v:
Internal Medicine
A 55-year-old man developed rapidly progressive glomerulonephritis and nephrotic syndrome. A kidney biopsy specimen showed diffuse proliferative and crescentic glomerulonephritis with monoclonal IgG1κ, humps, and nephritis-associated plasmin recepto
Autor:
Michio, Kuwahara, Eriko, Takehara, Yasunori, Sasaki, Haruna, Azetsu, Keita, Kusaka, Satomi, Shikuma, Wataru, Akita
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 20(1)
Cardiovascular events (CVEs) are major complications in patients with chronic kidney disease (CKD). However, few studies have investigated the effects of CVEs on end-stage renal disease (ESRD) and mortality of pre-dialysis patients. We followed 377 C
Autor:
Yasunori Sasaki, Tomoharu Yoshimine, Eriko Takehara, Keita Kusaka, Shinichi Uchida, Michio Kuwahara, Wataru Akita, Satomi Shikuma, Youhei Arai
Publikováno v:
Clinical and experimental nephrology. 20(4)
Renal anemia complicated with chronic kidney disease is usually treated with erythropoiesis-stimulating agents (ESAs). However, few studies have compared the early response of hemoglobin (Hb) to different kinds of ESAs. The effects of three types of